Delivery Order SPE2DR25D1002-SPE2DR26FGJ0E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) valued at $8,457.03. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. As a child contract under a larger...
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,762.29 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 29, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $16,372.29 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, awarded on August 4, 2025, represents a non-competitive set-aside contract and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,825.00 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units. The contract was competitively awarded without set-aside designation under a firm fixed price structure, with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $5,563.36. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $32,034.58 on May 12, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 13, 2025. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,859.44 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December...
- The Defense Logistics Agency awarded a $5,352.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 25, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This contract represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This contract, valued at $6,546.24, represents a firm fixed price delivery order with an ultimate completion date of June 17, 2025. The award was made on a competitive, non-set-aside basis and is performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGJ0EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) valued at $4,798.29. This is a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and represents a non-competitive set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for DESCOVY, an HIV treatment medication, exemplifies the company's role in supplying specialized pharmaceuticals to support military and veteran healthcare requirements. AmerisourceBergen's federal contract awards demonstrate consistent competitively-awarded agreements with firm fixed pricing across diverse therapeutic domains, reflecting the company's demonstrated capability to meet federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 10/27/25 |